NLSDays 2015: Meet international life science leaders and discuss the sector’s future at the Nordic region’s largest partnering meeting

/in , , , , , , , , /by

NLSDays September 9-10 at Stockholm Waterfront is the Nordic region’s premier life science event. The global life science sector is undergoing major structural changes, and as part of a strong established hub, companies in Sweden and the Nordic countries are of great interest when international investors and corporations are looking for new partners.

The entire value chain from basic research to the introduction of new therapies is subject to transformation – not least due to rapid developments in digital health. Life science companies therefore need to find new ways to collaborate and fund their projects. Since the Nordic region offers a modern, competitive environment for academia and research companies alike, the region has become highly attractive for the global life science industry.

  • NLSDays has become the most important meeting place for global investors and corporations that are looking for new collaborations in the Nordic region. The event is on course for record numbers and deals such as the recent one between Alligator Bioscience and Janssen Biotech which illustrates that Swedish companies offer major value to partners, says Jonas Ekstrand, CEO SwedenBIO, the Swedish national life science industry organization which founded the event three years ago.

Overall, the life science sector is currently very active in the Nordic countries. For example, the Oslo Cancer Cluster Innovation Park, an investment of around 100 million Euros opens today (24 August). Furthermore, AstraZeneca recently announced a Euros 260 million investment in a new plant for bio-pharmaceutical production and from January 2014, 18 life science companies across all subsectors from medtech to biopharma have been listed on Nasdaq Nordic at a combined value of about Euros 250 million (Source Nasdaq). Furthermore, initiatives and companies in new areas such as personalized medicine, digital health and outcomes based provision are emerging at an accelerating pace.

During Nordic Life Science Days 2015 the main theme is “The New Value Chain”. The 2 day program covers several sessions in which international life science leaders will discuss strategies on how new partnerships can be established and how medical research and the life science industry in the Nordics can contribute.

Super Sessions from the program:

  • International Investors (9 September at 11.30 – 12.30)

International life science investors talk about their investment models and what they look for from entrepreneurs.

  • Personalized Healthcare – Matching Medicines to Patients (September 10 at 08:45 – 09-45)

How will big data and new diagnostic methods impact the future of medical research and treatment modalities? Listen to how the Digital Doctor Watson can revolutionize health care.

  • Oncology 2025 (10 September 11.30 – 12.30)

Immuno-oncology is hotter than ever and there is an ongoing competition between the big global companies to take on the most promising projects. Representatives from several of the major players talk about their strategies.

Currently, 800 delegates are registered for this year’s NLSDays, which is 33% more than at the corresponding time last year. This strongly indicate that the meeting will attract over 1,000 participants, outnumbering last year’s number of delegates.

The conference is organized September 9-10, 2015 at Stockholm Waterfront Congress Centre, Nils Ericssons Plan 4 in Stockholm. More info on www.nlsdays.com.

 

About NLSDays

Founded in 2012 the Nordic Life Science Days has grown rapidly to become the largest Nordic partnering conference for the global life science industry. In 2014, 890 delegates from 28 countries attended the meeting. The 580 companies attending offered 490 licensing opportunities in the partnering system and during the two days 1600 one-on-one meetings were scheduled. Among the investors and big pharma already registered for the meeting in September 2015 are AbbVie, Alexion, Almi Invest, Astellas, AstraZeneca, Bayer HealthCare, Boehringer Ingelheim, Bristol-Myers Squibb, Cadila Pharma, Johnson & Johnson, HealthCap, Industrifonden, Karolinska Development, Merck-MSD, Novartis, Pfizer, Pierre Fabre, P.U.LS. AB, Recipharm, Roche, Seventure Partners, SR-One.

In addition to partnering, NLSDays also offers an exhibition and a seminar program with 10 super session and four topic specific workshops. Speakers include senior representatives from the global life science companies, investors, and academic leaders who will all share their expertise and views for the future.

About SwedenBIO

SwedenBIO who is the founder and organizer of the Nordic Life Science Days is the Swedish life science industry organization. Our nearly 200 members operate across all sub-sectors from pharmaceutical, biotechnology, medical technology to diagnostics. SwedenBIO serves to the benefit the entire life science industry in Sweden and is a member-driven, private, non-profit organization. The main objective is to improve the conditions for the life science industry for the benefit of industry growth and business development.

 

Oncology Super Session in Stockholm

/in , , , , , , /by

Oslo Cancer Cluster is hosting a Super Session at the Nordic Life Science Days in Stockholm. International thought leaders will discuss current game changing innovations and their impact on the industry in the years ahead.

Oncology is at the forefront of realizing the promises of precision medicine. Huge and complex datasets are exploited for novel drug development as well as for informed and real-time care decisions. Emerging Cancer immunotherapies represent a paradigm shift for cancer treatment triggering a global R&D race and novel partnerships. Furthermore, the convergence of the genetics and digital revolution creates novel types of products, companies and growth opportunities transforming the sector.

 

Moderator: Mr. Richard Godfrey, CEO, BergenBio, Norway

Session Outline:

 

Min Topic Speaker
5 Introduction by moderator ·        Dr. Richard Godfrey, CEO BerGenBio

 
10 Topic 1 –global company – perspectives from industry leader – Precision Medicine ·        Dr. Vaios Karanikas, Senior Biomarker and Experimental Medicine Leader, Tumor Immunology, Roche Pharmaceutical Research and Early Development, Innovation Center Zurich
10 Topic 2 – Digital Health company – Big Data / artificial intelligence -> impact on cancer R&D and care ·        Dr. Anthony Bak, Principal Data Scientist, Ayasdi
10 Topic 3 – global company – perspectives from industry leader – Immuno-Oncology ·        Dr. Tim Fisher, Global Lead, Immuno-Oncology / Oncology, Search & Evaluation, Bristol-Myers Squibb
25 Panel Discussion ·        All speakers, joined by Dr. Erik Lund, Director, Worldwide Licensing at MSD (Merck & Co., Inc.)

 

Target Audience: Start-ups, Biotechs, Pharma, investors, academic innovators, TTOs

 

Nordic Life Science Innovation Challenge

/in , , , , , /by

TalentEduc

Are you an aspiring to be a Life Science entrepreneur in Sweden, Norway, Finland or Denmark? Are you passionate about innovation? Do you need more practice on how to create, improve and present a business plan? Do you need professional advise? Then join in on two days to boost your business knowledge

  • Young entrepreneurs develop an already presented business case, provided by researchers from Copenhagen University, DTU, KI Innovation and KTH Innovation.
  • Working in a team to develop a business idea with other young talented professionals from different background and disciplines.
  • Educational training by solving challenges and working with mentors.
  • Commercializing innovative research ideas.
  • Nordic collaboration.

Oslo Cancer Cluster invites all young entrepreneurs to participate in the Nordic Life Science Innovation Challenge, Sept 5-6 in Copenhagen. Oslo Cancer Cluster has the opportunity to provide travel grants of NOK 2500/entrepreneur (up to four Norwegian Entrepreneurs).

You also have the opportunity to subm your research idea/case, you will have the chance to receiving a fresh and updated pitch for a business case based on your idea. Mentors will be present to facilitate the pitch development. You may enter into further collaboration with participants about the development of your idea if there is mutual interest.

The winning team will get free tickets for joining the NLSDays 2015 in Stockholm.

The event is totally free of charge. Oslo Cancer Cluster has the opportunity to provide travel grants of NOK 2500/entrepreneur, up to four Norwegian Entrepreneurs. Regarding the travel grant, please contact Jutta Heix.
The submission deadline is June 15, 2015. More information about the event can be found here www.biopeople.dk/Nordic_Life_Science

Download all relevant documents here:

NLS Days – time to sign up

/in , , , , , /by

Oslo Cancer Cluster is one of the supporting organizations for this years Nordic Life Science Days in Stockholm. Members of the cluster benefit from special rates on participation plus we host an Oncology 2025 Super Session.

In collaboration with LMI, Nansen Neuroscience Network and other healthcare industry actors in Norway, Oslo Cancer Cluster will attend NLSDays to promote Norwegian Healthcare Industry and the cluster members.

Questions regarding the conference may be directed to Jutta Heix, International Advisor or Elisabeth Kirkeng Andersen, Head of Communicaton.

Read the latest newsletter from NLSDays 2015 below or online

The 3rd annual Nordic Life Science Days partnering conference will take place September 9–10 in Stockholm, Sweden, at the Waterfront. NLSDays Super Sessions and Workshops feature top industry leaders and executives speaking on relevant trends to industry decision makers.


Already 50+ Company Presentations confirmed
Presenting at NLSDays is the perfect chance to increase your visibility and attract more partners. Pitch your company’s profile, strategy and objectives to a global audience. Be seen by BD executives, investors, analysts, media and get more activity in partneringONE®. Still a few 6mn and 12mn available slots, don’t miss the opportunity to book your presentation when registering.


Already 50+ Exhibitors confirmed
NLSDays brings hundreds of Life Science Industry leaders from 30+ countries together for 2 days of intensive networking. As an exhibitor, you will reach high-level executives and influential decision makers who come to NLSDays to meet with new players in the industry and initiate partnerships. Still a few 4sqm, 6sqm and 9sqm available stands, don’t miss the opportunity to book yours now.


Oncology 2025 Super Session
Hosted by Oslo Cancer Cluster. Oncology is at the forefront of realizing the promises of precision medicine. Huge and complex datasets are exploited for novel drugs devolpment as well as for informed and real-time care decisions. Emerging cancer immunotherapies represent a paradigm shift for cancer treatment triggening a global R&D race and novel partnerships. Furthermore, the convergence of the genetics and digital revolution creates novel types of products, companies and growth opportunities transforming the sector.


International Investors Super Session
Hosted by Business Sweden, co-hosted by Industrifonden and HealthCap. Meet the investors actively investing in European Life Sciences companies. What are they looking for? What are the learnings in biotech and medtech investing over the past decade? How are these learnings being applied in current investments decisions? How is the financial climate in Life Sciences today?


Member of a supporting organization?
Since Oslo  Cancer Cluster is a supporting organization, members get a discount. Send an e-mail to Elisabeth Kirkeng Andersen, Head of Communicaton to get the Promotion Code and benefit from discount on all registration fees. Remember that Regular Rate registration period ends on June 30, 2015.


Interested in sponsoring, exhibiting, presenting ? Contact: Olivier Duchamp, olivier.duchamp@bionordic.org